First Nebraska Trust Co Takes $20.05 Million Position in Cardinal Health, Inc. $CAH

Key Points

• First Nebraska Trust Co. acquired 84,400 Cardinal Health shares worth approximately $20.05 million, making CAH its 14th-largest portfolio holding at 1.6%. Institutional investors collectively own 87.17% of the stock.
• Cardinal Health’s latest quarter exceeded expectations, with EPS of $2.91 versus the $2.42 consensus and revenue up 5.8% year over year. The company provided fiscal 2027 EPS guidance of $12.40–$12.60 and declared a quarterly dividend of $0.5158 per share.
• Analysts remain broadly positive, with a “Moderate Buy” consensus and an average price target of $266.56, but substantial insider selling and concerns that a one-time tariff refund boosted earnings could weigh on investor confidence.

First Nebraska Trust Co bought a new stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 84,400 shares of the company's stock, valued at approximately $20,050,000. Cardinal Health makes up 1.6% of First Nebraska Trust Co's portfolio, making the stock its 14th biggest position.

A number of other institutional investors have also recently added to or reduced their stakes in CAH. BlackRock Inc. acquired a new stake in Cardinal Health in the 2nd quarter valued at $6,293,115,000. Norges Bank acquired a new position in shares of Cardinal Health during the fourth quarter worth about $790,344,000. Wellington Management Group LLP lifted its stake in shares of Cardinal Health by 153.2% during the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company's stock worth $911,010,000 after purchasing an additional 3,511,579 shares in the last quarter. Bank of New York Mellon Corp purchased a new stake in shares of Cardinal Health in the second quarter worth about $308,640,000. Finally, Deutsche Bank AG purchased a new stake in shares of Cardinal Health in the second quarter worth about $238,933,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 0.4%

Shares of NYSE CAH opened at $229.48 on Friday. Cardinal Health, Inc. has a fifty-two week low of $145.87 and a fifty-two week high of $258.30. The business has a 50 day moving average price of $232.02 and a two-hundred day moving average price of $217.86. The firm has a market cap of $53.37 billion, a PE ratio of 31.74, a price-to-earnings-growth ratio of 1.23 and a beta of 0.49.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.42 by $0.49. The company had revenue of $63.67 billion for the quarter, compared to analyst estimates of $65.15 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.Cardinal Health's quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the company posted $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, analysts anticipate that Cardinal Health, Inc. will post 12.54 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be issued a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Thursday, October 1st. Cardinal Health's dividend payout ratio (DPR) is currently 28.49%.

Key Stories Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Royal Bank of Canada initiated coverage with an “outperform” rating and a $276 price target, implying meaningful upside from recent trading levels. RBC cited Cardinal Health’s higher-margin services as a potential earnings-growth driver. RBC initiates coverage of Cardinal Health
• Positive Sentiment: Wall Street remains broadly constructive, with 16 analysts rating CAH a Buy and three assigning a Hold rating. The consensus rating is “Moderate Buy,” with an average price target of approximately $266.56. Zacks also identified Cardinal Health as a potentially attractive long-term value stock. Zacks value-stock analysis
• Positive Sentiment: Cardinal Health’s latest quarter delivered adjusted earnings per share of $2.91, well above the $2.42 consensus estimate, while revenue increased 5.8% year over year. Fiscal 2027 EPS guidance of $12.40–$12.60 supports the longer-term earnings case.
• Neutral Sentiment: The company declared a quarterly dividend of $0.5158 per share, equivalent to $2.06 annually and a yield of about 0.9%. The payout offers modest income support but is unlikely to be a major near-term catalyst.
• Negative Sentiment: Several executives sold sizable holdings around $235–$237 per share. CEO Jason Hollar sold 124,529 shares worth about $29.4 million, while other executive and insider sales—including those by Deborah Weitzman, Stephen Mason, Michelle Greene, Jessica Mayer and Mary Scherer—totaled roughly $20 million more. The concentrated selling and substantial reductions in insider ownership may encourage profit-taking concerns after CAH’s strong advance. Cardinal Health insider sales
• Negative Sentiment: Investors may also question the durability of the latest earnings beat because part of the improvement reportedly reflected a one-time tariff refund, potentially limiting the stock’s upside if recurring earnings growth does not match expectations. Cardinal Health earnings analysis

Insider Activity at Cardinal Health

In other news, CEO Stephen M. Mason sold 35,000 shares of the business's stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $236.40, for a total value of $8,274,000.00. Following the completion of the sale, the chief executive officer owned 18,061 shares of the company's stock, valued at approximately $4,269,620.40. The trade was a 65.96% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jason M. Hollar sold 80,000 shares of the company's stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $235.74, for a total transaction of $18,859,200.00. Following the completion of the sale, the chief executive officer owned 235,132 shares in the company, valued at approximately $55,430,017.68. This trade represents a 25.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 210,271 shares of company stock worth $49,626,657 over the last 90 days. Company insiders own 0.12% of the company's stock.

Wall Street Analyst Weigh In

CAH has been the topic of several recent research reports. Zacks Research lowered Cardinal Health from a "strong-buy" rating to a "hold" rating in a research report on Friday, June 12th. UBS Group increased their price objective on shares of Cardinal Health from $274.00 to $280.00 and gave the company a "buy" rating in a research report on Wednesday, August 12th. Wells Fargo & Company lifted their price objective on shares of Cardinal Health from $245.00 to $277.00 and gave the company an "overweight" rating in a research note on Wednesday, August 12th. Citigroup upped their target price on shares of Cardinal Health from $265.00 to $280.00 and gave the company a "buy" rating in a research note on Wednesday, August 12th. Finally, Robert W. Baird raised their price target on shares of Cardinal Health from $251.00 to $274.00 and gave the company an "outperform" rating in a report on Wednesday, August 12th. Sixteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat, Cardinal Health presently has a consensus rating of "Moderate Buy" and a consensus price target of $266.56.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source